- Home
- CMPX vs ANTA Comparison
CMPX vs ANTA Comparison
Compare CMPX & ANTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- ANTA
- Stock Information
- Founded
- CMPX 2014
- ANTA 2022
- Country
- CMPX United States
- ANTA Singapore
- Employees
- CMPX N/A
- ANTA N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- ANTA Investment Bankers/Brokers/Service
- Sector
- CMPX Health Care
- ANTA Finance
- Exchange
- CMPX Nasdaq
- ANTA Nasdaq
- Market Cap
- CMPX 291.8M
- ANTA 301.9M
- IPO Year
- CMPX N/A
- ANTA 2025
- Fundamental
- Price
- CMPX $2.97
- ANTA $11.99
- Analyst Decision
- CMPX Strong Buy
- ANTA Strong Buy
- Analyst Count
- CMPX 8
- ANTA 2
- Target Price
- CMPX $13.50
- ANTA $19.25
- AVG Volume (30 Days)
- CMPX 1.3M
- ANTA 37.7K
- Earning Date
- CMPX 08-11-2025
- ANTA 08-12-2025
- Dividend Yield
- CMPX N/A
- ANTA N/A
- EPS Growth
- CMPX N/A
- ANTA N/A
- EPS
- CMPX N/A
- ANTA 0.24
- Revenue
- CMPX N/A
- ANTA $56,997,910.00
- Revenue This Year
- CMPX N/A
- ANTA $53.90
- Revenue Next Year
- CMPX N/A
- ANTA $40.91
- P/E Ratio
- CMPX N/A
- ANTA $49.19
- Revenue Growth
- CMPX N/A
- ANTA 405.62
- 52 Week Low
- CMPX $1.15
- ANTA $10.19
- 52 Week High
- CMPX $4.08
- ANTA $27.72
- Technical
- Relative Strength Index (RSI)
- CMPX 50.84
- ANTA N/A
- Support Level
- CMPX $2.66
- ANTA N/A
- Resistance Level
- CMPX $3.47
- ANTA N/A
- Average True Range (ATR)
- CMPX 0.25
- ANTA 0.00
- MACD
- CMPX -0.02
- ANTA 0.00
- Stochastic Oscillator
- CMPX 38.27
- ANTA 0.00
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About ANTA Antalpha Platform Holding Company Ordinary Shares
Antalpha Platform Holding Co provides financing, technology and risk management solutions to the digital asset industry. It is a provider of supply chain financing solutions to institutional and corporate participants in the Bitcoin mining industry, offering loans secured by Bitcoin and Bitcoin mining machines. It has developed a technology platform, Antalpha Prime, which enables customers to apply for and manage their digital asset loans while allowing to closely monitor collateral positions.